Business Wire

SES/BCE

6.6.2019 08:57:11 CEST | Business Wire | Press release

Share
SES and Broadcasting Center Europe (BCE) Partner to Broadcast Asteroid Day 2019 Globally in HD

Viewers around the world will receive a month of programming in celebration of Asteroid Day, the official United Nations day of education and awareness about asteroids, thanks to a partnership between SES and BCE. The broadcast will feature pre-recorded and live High Definition (HD) content from Asteroid Day’s global programmes and events throughout June 2019, building to June 30 with coverage of over 2,000 events occurring in 190 countries.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190605005940/en/

As partners in the Asteroid Day initiative SES and BCE have teamed up to bring a month-long global broadcast of the related events to audiences around the world. BCE will produce the 6 hour live production out of Cercle Cité in Luxembourg city and provide all the playout services from its media centre in RTL City, for HD distribution over satellite as well as IP networks. The online distribution will be taken care of using BCE’s Freecaster Live Streaming solution, which will enable both live and VOD viewing on social networks and websites. For the satellite distribution, SES will broadcast the programming on five satellites to create a truly global footprint for Asteroid Day, a testament to the reach of SES. In Europe, Africa, and Asia the programming will be delivered Free-to-Air via satellite to Direct-to-Home (DTH) viewers, while in Latin and North America it will be integrated into the packages of multichannel video programming distributors (MVPDs) via satellite.

The programming will culminate on 28 June with Asteroid Day LIVE , a 24-hour live broadcast produced by Asteroid Day and sponsored by SES, BCE and the Government of Luxembourg. The marathon show will be hosted by prominent journalists from the BBC and CNN, who will be joined in studio and around the world by renowned astronauts, expert scientists, technologists, and researchers in planetary science.

“Luxembourg is home to a space industry and satellite telecoms infrastructure connecting Europe and the world,” said Marc Serres, CEO of the Luxembourg Space Agency. “The expertise and valuable support of leading companies such as SES and BCE play a key role in making Asteroid Day an international success and enable all of us to have a truly global conversation about space and asteroids.”

“BCE thrives with innovation and technology,” said Xavier Thillen, Head of Digital Media Operations at BCE. “Information is in our roots; we believe that instructing the world about asteroids has become an imperative. To do so, we are enthusiastic to use our state-of-the-art IP-based playout centre to broadcast this planetary event and reach the world with SES satellites fleet.”

“At SES, we value technology as a tool to positively impact and transform lives,” said Ruy Pinto, SES Chief Technology Officer. “We are proud to be a partner in this global awareness campaign to learn about asteroids, both the impact hazards they may pose and the resources they may one day yield. By leveraging multiple satellites, we are using the power of our global reach to deliver this important programming to millions of TV homes.”

View the full schedule

Worldwide audience can receive our dedicated satellite TV channel or stream our broadcast.

How to watch the TV broadcast

About SES

SES is the world’s leading satellite operator with over 70 satellites in two different orbits, Geostationary Orbit (GEO) and Medium Earth Orbit (MEO). It provides a diverse range of customers with global video distribution and data connectivity services through two business units: SES Video and SES Networks. SES Video reaches over 355 million TV homes, through Direct-to-Home (DTH) platforms and cable, terrestrial, and IPTV networks globally. The SES Video portfolio includes MX1, a leading media service provider offering a full suite of innovative services for both linear and digital distribution, and the ASTRA satellite system, which has the largest DTH television reach in Europe. SES Networks provides global managed data services, connecting people in a variety of sectors including telecommunications, maritime, aeronautical, and energy, as well as governments and institutions across the world. The SES Networks portfolio includes GovSat, a 50/50 public-private partnership between SES and the Luxembourg government, and O3b, the only non-geostationary system delivering fibre-like broadband services today. Further information is available at: www.ses.com

About Broadcasting Centre Europe (BCE)

Broadcasting Center Europe (BCE) is a European leader in media services, system integration and software development in the areas of television, radio, production and postproduction, telecommunication and IT. With its extensive experience on the media market, our team provides high-quality services and will always find the solution that matches your project and budget. With more than 200 highly qualified and motivated people, BCE serves about 400 clients in various sectors, such as TV channels, radio stations, film distributors, producers, advertising companies, telecommunications operators and public services. www.bce.lu

About Luxembourg Space Agency (LSA)

Established in 2018 with the goal of developing the national space sector, the Luxembourg Space Agency fosters new and existing companies, develops human resources, facilitates access to funding and provides support for academic research. The agency implements the national space economic development strategy, manages national space research and development programs, and leads the SpaceResources.lu initiative. The LSA also represents Luxembourg within the European Space Agency, as well as the space related programs of the European Union and the United Nations.

About Asteroid Day

Asteroid Day was co-founded in 2014 by the Asteroid Foundation, a nonprofit organization led by Dr. Brian May, astrophysicist and lead guitarist of QUEEN, Danica Remy, President of B612 Foundation, Rusty Schweickart, Apollo 9 Astronaut, and filmmaker Grig Richters. Asteroid Day events are held on 30 June each year to mark the anniversary of the 1908 Tunguska impact.

Asteroid Day was sanctioned by the United Nations in 2016, as a “global day of education to raise awareness about asteroids.” Asteroid Day is an educational program about asteroids/space – their role in the formation of our universe, how we can use their resources, how asteroids can pave the way for future exploration and how we can protect our planet from asteroid impacts.

MEDIA KIT, including quotes from supporters and partners, photos, video, and BROLL, are available in the Asteroid Day Newsroom

Join the Asteroid Day conversation:
@asteroidday
@SES_satellites
@BCE_Lux
#AsteroidDay, #AsteroidDayLive
Facebook
YouTube

Contact:

Francesca De Florio SES Corporate Communications Tel. +352 710 725 500 francesca.deflorio@ses.com

Laurent Seve BCE Marketing Tel. +352 24 80 7111 laurent_seve@bce.lu

Lynn Robbroeckx LSA Communication Tel: +352 621 325 604 lynn.robbroeckx@space-agency.lu

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

U.S. FDA Grants Priority Review to BeOne Medicines’ BRUKINSA Combination in First-Line Mantle Cell Lymphoma4.11.2026 15:13:00 CET | Press release

If approved, BRUKINSA plus rituximab would be the first and only chemotherapy-free, BTK inhibitor-based regimen for adult patients with previously untreated mantle cell lymphomaApplication supported by Phase 3 MANGROVE data, showing a 43% reduction in the risk of progression or death versus bendamustine plus rituximabFull MANGROVE results to be presented during the Plenary Scientific Session at the 68th American Society of Hematology Annual Meeting BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to the supplemental New Drug Application (sNDA) for BRUKINSA® (zanubrutinib) in combination with rituximab for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL). The application is supported by data from the pivotal Phase 3 MANGROVE study, in which this chemotherapy-free regimen significantly reduced the risk of dis

Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement4.11.2026 15:00:00 CET | Press release

This framework agreement provides all entities subject to the French Public Procurement Code with simplified access to a support alternative enabling them to control their costs, preserve their freedom of technological choice and free themselves from vendor-imposed upgrade cycles Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™ and the leading third-party support provider for Oracle, SAP and VMware software, today announced that it had been selected as the awardee of the third-party support service lots (TMA) by CANUT, the French public purchasing center specializing in digital technology and telecommunications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104431817/en/ Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement Eligible public organizations subject to the French Public Procurement Code can now benefit from Rimini Street services for their Oracle, SAP, VMw

Incyte to Present New Data Highlighting Progress Across its Hematology Portfolio at ASH 20264.11.2026 15:00:00 CET | Press release

New data in myeloproliferative neoplasms (MPNs) will include INCA033989, Incyte’s first-in-class, mutant calreticulin (mutCALR)-targeted monoclonal antibody, in first-line myelofibrosis (MF); and preclinical findings for Incyte’s next-generation mutCALR- and JAK2V617F-targeted compoundsUpdated results for INCA033989 in second-line MF and second-line essential thrombocythemia (ET) will build on previously presented datasetsLong-term Phase 1/2 data further characterize the potential of latarcibart (VGA039), an investigational Protein S-targeting antibody, as prophylaxis in adolescents and adults with von Willebrand disease (VWD)More than 30 abstracts will highlight progress across Incyte’s broader hematology portfolioIncyte will host an investor event and webcast on Saturday, December 12, 2026 from 7:30 – 9:00 p.m. CT (8:30 – 10:00 p.m. ET) Incyte (Nasdaq:INCY) today announced that new data highlighting progress across its hematology portfolio will be presented across more than 30 abstra

Zenitar Announces Initiation of International Randomized Study of Flonoltinib Maleate in Patients with Myelofibrosis and Related American Society of Hematology 2026 Meeting Presentations4.11.2026 15:00:00 CET | Press release

Chengdu Zenitar Biomedical Technology Co., Ltd. (Zenitar) is developing flonoltinib maleate (FM), a first-in-class oral JAK2/FLT3/CDK6 inhibitor for myeloproliferative neoplasms (MPNs), including myelofibrosis (MF) and polycythemia vera (PV). Zenitar launched randomized Phase 2 FM-MF-02 (NCT07750574) in the US, Canada and Brazil to select Phase 3 dose for JAKi-naïve and refractory MF. Randomized FMF-02 (NCT06457425) met its week-24 endpoints: superior SVR35 and TSS50 with FM 50/100mg versus ruxolitinib; previous data presented orally at ASH24 (#486) and ASH25 (#908). ASH 2026 presence covers FMF-02 long-term follow-up (oral presentation, #411, December 12, 4:30pm) and refractory PV Phase 2 data (poster, #3765, December 13, 6pm), both in Session 634. “Over the 15 years since the initial FDA approval of Ruxolitinib, JAKi have markedly improved the prognosis of many patients with MF. The long-term data show significant room for improvement for this key therapeutic class in terms of both e

Trained Therapeutix Discovery Appoints Andrew Glass as Chief Executive Officer4.11.2026 14:41:00 CET | Press release

Trained Therapeutix Discovery ("TTxD"), a pioneering immunotherapy company founded by the Jean Boulle Group and the Heritage Group, which is developing nanomedicines to regulate innate immunity, announces the appointment of Andrew Glass as Chief Executive Officer with immediate effect. Mr. Glass has more than 20 years of leadership experience in the life sciences industry as Chief Executive Officer of Vivasure Medical and previously from over 15 years in senior leadership roles at Abbott. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104178009/en/ Andrew Glass, CEO, TTxD Following the previously announced changes to the Company’s Board earlier this year, Mr. Glass joins the Company as it transitions from preclinical stage to being a clinical-stage organisation. His expertise in developmental strategy, financing and organisational growth is focussed on expediting the delivery of the aims associated with TTxD’s proprietary

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye